The
nucleocapsid
(N-)protein
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
a
key
role
in
viral
assembly
and
scaffolding
the
RNA.
It
promotes
liquid-liquid
phase
separation
(LLPS),
forming
dense
droplets
that
support
ribonucleoprotein
particles
with
as-of-yet
unknown
macromolecular
architecture.
Combining
biophysical
experiments,
molecular
dynamics
simulations,
analysis
mutational
landscape,
we
describe
heretofore
oligomerization
site
contributes
to
LLPS,
is
required
for
higher-order
protein-nucleic
acid
complexes,
coupled
large-scale
conformational
changes
N-protein
upon
nucleic
binding.
self-association
interface
located
leucine-rich
sequence
intrinsically
disordered
linker
between
folded
domains
formed
by
transient
helices
assembling
into
trimeric
coiled-coils.
Critical
residues
stabilizing
hydrophobic
electrostatic
interactions
adjacent
are
highly
protected
against
mutations
viable
SARS-CoV-2
genomes,
motif
conserved
across
related
coronaviruses,
thus
presenting
target
antiviral
therapeutics.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2021,
Номер
unknown
Опубликована: Дек. 21, 2021
Abstract
The
Omicron
SARS-CoV-2
virus
contains
extensive
sequence
changes
relative
to
the
earlier
arising
B.1,
B.1.1
and
Delta
variants
that
have
unknown
effects
on
viral
infectivity
response
existing
vaccines.
Using
virus-like
particles
(SC2-VLPs),
we
examined
mutations
in
all
four
structural
proteins
found
showed
3-fold
higher
capsid
assembly
cell
entry
Delta,
a
property
conferred
by
S
N
protein
mutations.
Thirty-eight
antisera
samples
from
individuals
vaccinated
with
Pfizer/BioNTech,
Moderna,
Johnson
&
vaccines
convalescent
sera
unvaccinated
COVID-19
survivors
had
15-fold
lower
efficacy
prevent
transduction
VLPs
containing
ancestral
B.1
spike
protein.
A
third
dose
of
Pfizer
vaccine
elicited
substantially
neutralization
titers
against
Omicron,
resulting
detectable
neutralizing
antibodies
8
out
subjects
compared
1
pre-boost.
Furthermore,
monoclonal
antibody
therapeutics
Casirivimab
Imdevimab
robust
activity
or
but
no
VLPs.
Our
results
suggest
is
more
efficient
at
triggered
previous
infection,
least
prior
boost,
will
limited
ability
neutralize
Omicron.
In
addition,
some
currently
available
not
be
useful
treating
Omicron-infected
patients.
One-Sentence
Summary
enhanced
only
weakly
neutralized
vaccination
without
boost
therapeutics.
Abstract
Worldwide
SARS-CoV-2
sequencing
efforts
track
emerging
mutations
in
its
spike
protein,
as
well
characteristic
other
viral
proteins.
Besides
their
epidemiological
importance,
the
observed
sequences
present
an
ensemble
of
viable
protein
variants,
and
thereby
a
source
information
on
structure
function.
Charting
mutational
landscape
nucleocapsid
(N)
that
facilitates
assembly,
we
observe
variability
exceeding
with
more
than
86%
residues
can
be
substituted,
average
by
three
to
four
different
amino
acids.
However,
exhibit
uneven
distribution
tracks
known
structural
features
but
also
reveals
highly
protected
stretches
unknown
One
these
conserved
regions
is
central
disordered
linker
proximal
N-G215C
mutation
has
become
dominant
Delta
variant,
outcompeting
G215
variants
without
further
or
N-protein
substitutions.
Structural
models
suggest
G215C
stabilizes
transient
helices
serving
protein–protein
interaction
interfaces.
Comparing
variant
ancestral
version
biophysical
experiments,
find
significantly
compact
less
structure.
exhibits
substantially
stronger
self-association,
shifting
unliganded
from
dimeric
tetrameric
oligomeric
state,
which
leads
enhanced
coassembly
nucleic
This
suggests
sequence
mirrored
high
plasticity
properties,
hypothesize
exploited
achieve
greater
efficiency
infectivity.
Nature Biotechnology,
Год журнала:
2022,
Номер
41(1), С. 140 - 149
Опубликована: Окт. 10, 2022
Abstract
Understanding
the
mechanisms
of
coronavirus
disease
2019
(COVID-19)
severity
to
efficiently
design
therapies
for
emerging
virus
variants
remains
an
urgent
challenge
ongoing
pandemic.
Infection
and
immune
reactions
are
mediated
by
direct
contacts
between
viral
molecules
host
proteome,
vast
majority
these
virus–host
(the
‘contactome’)
have
not
been
identified.
Here,
we
present
a
systematic
contactome
map
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
with
human
encompassing
more
than
200
binary
intraviral
protein–protein
interactions.
We
find
that
proteins
genetically
associated
comorbidities
illness
long
COVID
enriched
in
SARS-CoV-2
targeted
network
communities.
Evaluating
contactome-derived
hypotheses,
demonstrate
NSP14
activates
nuclear
factor
κB
(NF-κB)-dependent
transcription,
even
presence
cytokine
signaling.
Moreover,
several
tested
proteins,
genetic
knock-down
substantially
reduces
replication.
Additionally,
show
USP25
this
effect
is
phenocopied
small-molecule
inhibitor
AZ1.
Our
results
connect
architecture
COVID-19
offer
potential
therapeutic
targets.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Янв. 31, 2023
Knowledge
of
the
fitness
effects
mutations
to
SARS-CoV-2
can
inform
assessment
new
variants,
design
therapeutics
resistant
escape,
and
understanding
functions
viral
proteins.
However,
experimentally
measuring
is
challenging:
we
lack
tractable
lab
assays
for
many
proteins,
comprehensive
deep
mutational
scanning
has
been
applied
only
two
Here
develop
an
approach
that
leverages
millions
publicly
available
sequences
estimate
mutations.
We
first
calculate
how
independent
occurrences
each
mutation
are
expected
be
observed
along
phylogeny
in
absence
selection.
then
compare
these
observations
actual
effect
mutation.
These
estimates
correlate
well
with
measurements.
For
most
genes,
synonymous
nearly
neutral,
stop-codon
deleterious,
amino-acid
have
a
range
effects.
some
accessory
proteins
under
little
no
provide
interactive
visualizations
all
(https://jbloomlab.github.io/SARS2-mut-fitness/).
The
framework
describe
applicable
any
virus
which
number
sufficiently
large
neutral
observed.
The
nucleocapsid
(N-)protein
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
a
key
role
in
viral
assembly
and
scaffolding
the
RNA.
It
promotes
liquid-liquid
phase
separation
(LLPS),
forming
dense
droplets
that
support
ribonucleoprotein
particles
with
as-of-yet
unknown
macromolecular
architecture.
Combining
biophysical
experiments,
molecular
dynamics
simulations,
analysis
mutational
landscape,
we
describe
heretofore
oligomerization
site
contributes
to
LLPS,
is
required
for
higher-order
protein-nucleic
acid
complexes,
coupled
large-scale
conformational
changes
N-protein
upon
nucleic
binding.
self-association
interface
located
leucine-rich
sequence
intrinsically
disordered
linker
between
folded
domains
formed
by
transient
helices
assembling
into
trimeric
coiled-coils.
Critical
residues
stabilizing
hydrophobic
electrostatic
interactions
adjacent
are
highly
protected
against
mutations
viable
SARS-CoV-2
genomes,
motif
conserved
across
related
coronaviruses,
thus
presenting
target
antiviral
therapeutics.